Sumitomo Mitsui Trust Group Inc. 13D and 13G filings for Adaptive Biotechnologies Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-04 06:13 am Sale | 2024-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | Sumitomo Mitsui Trust Group Inc. | 6,833,137 4.600% | -900,747 (-11.65%) | Filing |
| 2024-11-05 06:07 am Purchase | 2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT | Sumitomo Mitsui Trust Group Inc. | 7,733,884 5.240% | 7,733,884 (New Position) | Filing |